Journal for ImmunoTherapy of Cancer Impact Factor, Quartile, Indexing, Ranking
Journal for ImmunoTherapy of Cancer (JIC) is a scholarly journal dedicated to publishing research in the field of Pharmacology, Toxicology and Pharmaceutics, and Published by BMJ. The Print-ISSN of Journal for ImmunoTherapy of Cancer is 2051-1426 and its abbreviation is J Immunother Cancer.
The latest Impact Factor of the Journal for ImmunoTherapy of Cancer for 2026-2027 is 10.9.
The Publication fees (APC) is 2885 USD.
Journal for ImmunoTherapy of Cancer Aim and Scope
The Journal for ImmunoTherapy of Cancer (JITC) is the open access, peer reviewed, online journal of the Society for Immunotherapy of Cancer (SITC). The journal publishes articles on all aspects of tumor immunology and cancer immunotherapy and, in doing so, aims to enrich communication and advance scientific understanding among the many stakeholders in this rapidly evolving field. Topics of interest range widely across the basic science-translational-clinical spectrum and include tumor-host interactions, the tumor microenvironment, animal models, predictive and prognostic immune biomarkers, novel pharmaceutical and cellular therapies, vaccines, combination immune-based therapies, and immune-related toxicity.
Journal for ImmunoTherapy of Cancer Details
| Journal title | Journal for ImmunoTherapy of Cancer (JIC) |
| Abbreviation | J Immunother Cancer |
| Print ISSN | 2051-1426 |
| Publisher Name | BMJ |
| Editor-in-chief | James L. Gulley, MD, PhD, FACP |
| Subject Category | Pharmacology, Toxicology and Pharmaceutics |
| Access type | 🟢 Open Access |
| Status | 🟢 Active |
Journal for ImmunoTherapy of Cancer Metrics and Rankings
In the context of academic journals, "Metrics and Rankings" refer to various measures and evaluations used to assess the quality, influence, and impact of a journal.
Below are the metrics and rankings for the journal Journal for ImmunoTherapy of Cancer
| Acceptance rate | 23%% |
| Impact Factor | 10.9 |
| SJR | 3.403 |
| SNIP | 1.851 |
| Ranking | 494 |
| CiteScore | 16.8 |
| H-Index | 100 |
| Quartile | Q1 |
Journal for ImmunoTherapy of Cancer Article Processing Charge (APC)
| Article Publication Charges (APC) |
2885 USD ✳️Without APC Pharmacology, Toxicology and Pharmaceutics Journals |
Journal for ImmunoTherapy of Cancer Abstracting and Indexing
Abstracting and Indexing (A&I) refers to the processes that help organize and categorize academic journals, making them easier to find and access for researchers and scholars
| Abstracting and Indexing |
Journal for ImmunoTherapy of Cancer Submission
If you would like to submit a manuscript or visit the journal's website, please click on the link below.
| Journal Submission | 🔗 Journal Website |
